Marcelissen T - Search Results

1

Oral Pharmacologic Management of Overactive Bladder Syndrome: Where Do We Stand?

Marcelissen T, Rashid T, Antunes Lopes T, Delongchamps NB, Geavlete B, Rieken M, Cornu JN, Rahnama'i MS; EAU Young Academic Urologists (YAU) functional urology working group. Marcelissen T, et al. Eur Urol Focus. 2019 Nov;5(6):1112-1119. doi: 10.1016/j.euf.2018.03.011. Epub 2018 Apr 4. Eur Urol Focus. 2019. PMID: 29625926 Review.

2

Long-term results of sacral neuromodulation with the tined lead procedure.

Marcelissen TA, Leong RK, de Bie RA, van Kerrebroeck PE, de Wachter SG. Marcelissen TA, et al. J Urol. 2010 Nov;184(5):1997-2000. doi: 10.1016/j.juro.2010.06.142. Epub 2010 Sep 18. J Urol. 2010. PMID: 20850820

3

Satisfaction and patient experience with sacral neuromodulation: results of a single center sample survey.

Leong RK, Marcelissen TA, Nieman FH, De Bie RA, Van Kerrebroeck PE, De Wachter SG. Leong RK, et al. J Urol. 2011 Feb;185(2):588-92. doi: 10.1016/j.juro.2010.09.090. Epub 2010 Dec 18. J Urol. 2011. PMID: 21168881

4

The use of bilateral sacral nerve stimulation in patients with loss of unilateral treatment efficacy.

Marcelissen TA, Leong RK, Serroyen J, van Kerrebroeck PE, De Wachter SG. Marcelissen TA, et al. J Urol. 2011 Mar;185(3):976-80. doi: 10.1016/j.juro.2010.10.065. Epub 2011 Jan 19. J Urol. 2011. PMID: 21247601 Clinical Trial.

5

The effect of pulse rate changes on the clinical outcome of sacral neuromodulation.

Marcelissen TA, Leong RK, Nieman FH, de Bie RA, van Kerrebroeck PE, de Wachter SG. Marcelissen TA, et al. J Urol. 2011 May;185(5):1781-5. doi: 10.1016/j.juro.2010.12.089. Epub 2011 Mar 21. J Urol. 2011. PMID: 21420118

6

Sacral neuromodulation in patients with idiopathic overactive bladder after initial botulinum toxin therapy.

Smits MA, Oerlemans D, Marcelissen TA, Van Kerrebroeck PE, De Wachter SG. Smits MA, et al. Among authors: marcelissen ta. J Urol. 2013 Dec;190(6):2148-52. doi: 10.1016/j.juro.2013.07.017. Epub 2013 Jul 17. J Urol. 2013. PMID: 23872028

7

Long-term follow-up of intravesical botulinum toxin-A injections in women with idiopathic overactive bladder symptoms.

Marcelissen TA, Rahnama'i MS, Snijkers A, Schurch B, De Vries P. Marcelissen TA, et al. World J Urol. 2017 Feb;35(2):307-311. doi: 10.1007/s00345-016-1862-y. Epub 2016 Jun 7. World J Urol. 2017. PMID: 27272312

8

Long-term compliance and results of intravesical botulinum toxin A injections in male patients.

Rahnama'i MS, Marcelissen TAT, Brierley B, Schurch B, de Vries P. Rahnama'i MS, et al. Among authors: marcelissen tat. Neurourol Urodyn. 2017 Sep;36(7):1855-1859. doi: 10.1002/nau.23196. Epub 2017 Jan 13. Neurourol Urodyn. 2017. PMID: 28084637

9

Overactive bladder symptoms after midurethral sling surgery in women: Risk factors and management.

Marcelissen T, Van Kerrebroeck P. Marcelissen T, et al. Neurourol Urodyn. 2018 Jan;37(1):83-88. doi: 10.1002/nau.23328. Epub 2017 Jun 20. Neurourol Urodyn. 2018. PMID: 28631830 Review.

10

The efficacy of botulinum toxin A and sacral neuromodulation in the management of interstitial cystitis (IC)/bladder pain syndrome (BPS), what do we know? ICI-RS 2017 think thank, Bristol.

Rahnama'i MS, Marcelissen T, Apostolidis A, Veit-Rubin N, Schurch B, Cardozo L, Dmochowski R. Rahnama'i MS, et al. Among authors: marcelissen t. Neurourol Urodyn. 2018 Jun;37(S4):S99-S107. doi: 10.1002/nau.23493. Epub 2018 Jan 24. Neurourol Urodyn. 2018. PMID: 29363792 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

58 results

Search Page